NIH Clinical Trial Integrity Act

# NIH Clinical Trial Integrity Act Summary **What the Bill Would Do:** The NIH Clinical Trial Integrity Act would establish stronger oversight and quality standards for clinical trials funded or conducted by the National Institutes of Health (NIH). The bill aims to ensure that clinical trials—research studies that test new medical treatments on human participants—maintain high ethical and scientific standards and that results are reported accurately and transparently. **Who It Affects:** This legislation would primarily affect researchers and institutions that conduct NIH-funded clinical trials, as well as patients who participate in these studies. It could also impact the broader medical research community's practices and the general public, who benefit from reliable clinical trial data when new treatments become available. **Current Status:** The bill was introduced in the 119th Congress by Representative Robin L.

Kelly (D-IL) and is currently in committee, meaning it has not yet been voted on by the full House of Representatives. No further action has been taken at this time. *Note: Limited details are available in the provided information. For a complete understanding of specific provisions, the full bill text would need to be reviewed.*.